Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Early detection: the impact of genomics.

van Lanschot MCJ, Bosch LJW, de Wit M, Carvalho B, Meijer GA.

Virchows Arch. 2017 Aug;471(2):165-173. doi: 10.1007/s00428-017-2159-2. Epub 2017 Jun 1. Review.

PMID:
28573511
2.

Molecular stool testing as an alternative for surveillance colonoscopy: a cross-sectional cohort study.

van Lanschot MC, Carvalho B, Coupé VM, van Engeland M, Dekker E, Meijer GA.

BMC Cancer. 2017 Feb 7;17(1):116. doi: 10.1186/s12885-017-3078-y.

3.

Colorectal cancer screening by colonoscopy: putting it into perspective.

Vleugels JL, van Lanschot MC, Dekker E.

Dig Endosc. 2016 Apr;28(3):250-9. doi: 10.1111/den.12533. Epub 2015 Sep 23. Review.

PMID:
26257272
4.

Measuring residual estrogen receptor availability during fulvestrant therapy in patients with metastatic breast cancer.

van Kruchten M, de Vries EG, Glaudemans AW, van Lanschot MC, van Faassen M, Kema IP, Brown M, Schröder CP, de Vries EF, Hospers GA.

Cancer Discov. 2015 Jan;5(1):72-81. doi: 10.1158/2159-8290.CD-14-0697. Epub 2014 Nov 7.

Supplemental Content

Loading ...
Support Center